1. Home
  2. PLSM vs CRVO Comparison

PLSM vs CRVO Comparison

Compare PLSM & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pulsenmore Ltd. Ordinary Shares

PLSM

Pulsenmore Ltd. Ordinary Shares

N/A

Current Price

$2.57

Market Cap

22.3M

Sector

Health Care

ML Signal

N/A

Logo CervoMed Inc.

CRVO

CervoMed Inc.

HOLD

Current Price

$2.60

Market Cap

25.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PLSM
CRVO
Founded
2014
2001
Country
Israel
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
22.3M
25.9M
IPO Year
2025
2011

Fundamental Metrics

Financial Performance
Metric
PLSM
CRVO
Price
$2.57
$2.60
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$23.00
AVG Volume (30 Days)
38.5K
316.7K
Earning Date
03-30-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$4,006,510.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.53
$2.13
52 Week High
$12.97
$10.89

Technical Indicators

Market Signals
Indicator
PLSM
CRVO
Relative Strength Index (RSI) 31.73 42.92
Support Level N/A $2.47
Resistance Level $3.82 $3.20
Average True Range (ATR) 0.28 0.16
MACD -0.01 0.00
Stochastic Oscillator 12.37 17.14

Price Performance

Historical Comparison
PLSM
CRVO

About PLSM Pulsenmore Ltd. Ordinary Shares

Pulsenmore Ltd is an emerging medical device company engaged in the research, development, manufacturing, marketing, and sale of non-invasive portable ultrasound solutions for home use. Its products include the Pulsenmore ES and Pulsenmore FC, along with the early-stage Pulsenmore MC, collectively referred to as Pulsenmore Products, enabling remote ultrasound scans in gynecology and other fields such as pulmonary, cardiology, and urology through telemedicine. The Company operates in a single segment focused on developing and commercializing portable ultrasound technologies, with Israel contributing the majority of its revenue.

About CRVO CervoMed Inc.

CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod, has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.

Share on Social Networks: